ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstracts tagged "Mouse model"

  • Abstract Number: 017 • 2020 Pediatric Rheumatology Symposium

    MyD88 S209R-Mediated Immune Dysregulation in Mouse Models of Arthritis

    Sufia Bakshi1, Malika Waschmann 2, Anders Lindstedt 2, Emily Rominger 2, Robert Colbert 3 and Keith Sikora 4, 1National Institutes of Health, Bethesda, Maryland, 2National Institutes of Health, Bethesda, 3NIH/NIAMS, Bethesda, Maryland, 4National Institutes of Health Clinical Center, Bethesda, Maryland

    Background/Purpose: MYD88 is a critical adaptor protein that connects Toll-like and IL-1 receptor signaling to activation of NF-kB. We previously reported a heterozygous de novo mutation in MYD88 (S222R)…
  • Abstract Number: 85 • 2019 ACR/ARP Annual Meeting

    Selective Inhibition of the Immunoproteasome with KZR-616 Blocks Multiple Cell Signaling Pathways, Plasma Cell Signatures and Myeloid Cell Associated Damage in the NZB/W Lupus Nephritis Model

    Tony Muchamuel1, Janet Anderl 1, R Andrea Fan 1, Henry Johnson 1, Dustin McMinn 1 and Christopher Kirk 1, 1Kezar Life Sciences, South San Francisco, CA

    Background/Purpose: The immunoproteasome is a distinct class of proteasome found predominantly in immune effector cells and has been shown to play a distinct role in…
  • Abstract Number: 672 • 2019 ACR/ARP Annual Meeting

    Mouse SLE Studies Do Not Describe Human SLE

    Ecem Sevim1, Linjia Jia 2, David Fernandez 3 and Michael Lockshin 4, 1Hospital for Special Surgery, New York, NY, 2Weill Cornell Medicine, New York, NY, 3Hospital for Special Surgery, Mary Kirkland Center for Lupus Research, New York, NY, 4Hospital for Special Surgery, Barbara Volcker Center for Women and Rheumatic Diseases, New York, NY

    Background/Purpose: Although mouse models of systemic lupus erythematosus (SLE) are useful proxies for human illness, they are heterogeneous, and publications about mouse SLE may not…
  • Abstract Number: 991 • 2019 ACR/ARP Annual Meeting

    Identification of Citrullinated Peptide Specific T-cells in Humanized Mice Immunized with Citrullinated Peptides

    Matthew McElwee1, Thamotharampillai Dileepan 1 and Marc Jenkins 1, 1University of Minnesota, Minneapolis, MN

    Background/Purpose: Seropositive rheumatoid arthritis (RA) is a T-cell mediated disease that is characterized by the presence of antibodies to proteins that have undergone the post-translational…
  • Abstract Number: 1771 • 2019 ACR/ARP Annual Meeting

    MyD88 S209R Enhances Inflammation in Mouse Models of Arthritis

    Sufia Bakshi1, Anders Lindstedt 2, Malika Waschmann 3, Wanxia Tsai 1, Robert Colbert 4 and Keith Sikora 1, 1National Institutes of Health, Bethesda, MD, 2NIH, Bethesda, MD, 3Oregon Health and Science University, Portland, OR, 4Pediatric Clinical Trials Unit, Pediatric Translational Research Branch, NIAMS, NIH, Bethesda, MD

    Background/Purpose: MyD88 is a critical adaptor protein that connects Toll-like and IL-1 receptor signaling to activation of NF-kB. We previously reported a heterozygous de novo gain-of-function mutation in MYD88 (S222R)…
  • Abstract Number: 1773 • 2019 ACR/ARP Annual Meeting

    The Card9-Neutrophil Signaling Axis Is Critical to Induction of Th17-Mediated Arthritis in SKG Mice

    Ruth Napier1, Ellen Lee 1, Emily Vance 1, Beatitude Steffen 2, Shimon Sakaguchi 3 and Holly Rosenzweig 4, 1Oregon Health & Science University and Portland VA Hospital, Portland, OR, 2Oregon Health & Science University and Portland VA Hospital, Portland, 3Osaka University, Osaka, Japan, 4Oregon Health & Science University and Portland VA Hospital, Oregon

    Background/Purpose: Caspase recruitment domain-containing protein 9 (CARD9) is an adaptor protein downstream of C-type lectin receptor signaling within myeloid cells. CARD9 is critical for anti-fungal immunity;…
  • Abstract Number: 1781 • 2019 ACR/ARP Annual Meeting

    Cytokine Dependence of Enthesis-resident Lymphocytes in Murine Spondyloarthritis

    Mederbek Matmusaev 1, Emma Haley1, Imtiyaz Hossain 1 and Joerg Ermann 1, 1Brigham and Women's Hospital, Boston

    Background/Purpose: Enthesis-resident CD4-CD8- double-negative (DN) T cells have been implicated in the pathogenesis of spondyloarthritis. Overexpression of IL-23 in adult mice activates these cells to…
  • Abstract Number: 1910 • 2019 ACR/ARP Annual Meeting

    Inflammatory Processes in Experimental Spondyloarthritis Are Accompanied by Formation of Ectopic Lymphoid Structures and B Cell Lineage Alterations in the Bone Marrow

    Merlijn Kaaij1, Jan Piet van Hamburg 1, Jasper Rip 2, George Kollias 3, Leonie van Duivenvoorde 1, Martijn Nolte 4, Dominique Baeten 1 and Sander Tas 1, 1Amsterdam Rheumatology & immunology Center, Amsterdam UMC/University of Amsterdam, Amsterdam, Netherlands, 2Department of Pulmonary Medicine, Erasmus MC, Rotterdam, Rotterdam, Netherlands, 3Division of Immunology, Biomedical Sciences Center ”Alexander Fleming”, Vari, Greece, Vari, Greece, 4Sanquin Research and Landsteiner Laboratory, Molecular & Cellular Hemostasis, Amsterdam UMC/University of Amsterdam, Amsterdam, Netherlands

    Background/Purpose: Tumour necrosis factor a (TNF) is important in immune-mediated inflammatory diseases such as spondyloarthritis (SpA). Transmembrane (tm)TNF-transgenic (tg) mice that overexpress tmTNF develop typical…
  • Abstract Number: 2042 • 2019 ACR/ARP Annual Meeting

    Intestinal Microbiota Alters Th1/Th17 Balance but Is Dispensable for the Development of Systemic Autoimmune Disease in BXD2 Mice

    Huixian Hong1, Qi Wu 1, PingAr Yang 1, Bao Luo 2, Alex Essman 2, Oluwagbemiga Ojo 2, Michael R. Crowley 3, David K. Crossman 3, Casey D. Morrow 4, Jeremy B. Foote 5, Trenton R. Schoeb 6, Charles O. Elson 7, Hui-Chen Hsu 8 and John D. Mountz 9, 1Division of Clinical Immunology and Rheumatology, Department of Medicine, University of Alabama at Birmingham, Birmingham, AL, 2Division of Clinical Immunology and Rheumatology, Department of Medicine, University of Alabama at Birmingham, Birmingham, 3Department of Genetics, University of Alabama at Birmingham, Birmingham, 4Department of Cell, Developmental, and Integrative Biology, University of Alabama at Birmingham, Birmingham, 5Department of Microbiology, University of Alabama at Birmingham, Birmingham, 6Department of Genetics, Animal Resources Program, University of Alabama at Birmingham, Birmingham, 7Department of Medicine, University of Alabama at Birmingham, Birmingham, 81Division of Clinical Immunology and Rheumatology, Department of Medicine, University of Alabama at Birmingham, Birmingham, 9Division of Clinical Immunology and Rheumatology, Department of Medicine, University of Alabama at Birmingham & University of Alabama at Birmingham and Birmingham VA Medical center, Birmingham

    Background/Purpose: Intestinal microbiota dysbiosis has been implicated in the pathogenesis of autoimmune disease.  How the microbiota affects the peripheral immune system leading to the development…
  • Abstract Number: 70 • 2019 ACR/ARP Annual Meeting

    Angiotensin Receptor Blockers Prevent Loss of Dendritic Complexity in a Lupus Mouse Model of Cognitive Impairment

    Lara El Khoury1, Nina Kello 1, Kristiana Hanna 2, Bruce Volpe 3 and Betty Diamond 4, 1Zucker School of Medicine at Hofstra/Northwell, Manhasset, NY, 2Albany Medical College, Albany, NY, 3Feinstein Institutes for Medical Research, Manhasset, NY, 4Feinstein Institutes for Medical Research, Manhasset

    Background/Purpose: Cognitive dysfunction affects the majority of patients with systemic lupus erythematosus (SLE), however it is grossly under-recognized, the pathogenesis is poorly understood, and no…
  • Abstract Number: 72 • 2019 ACR/ARP Annual Meeting

    The Single-cell Transcriptomic Landscape of NZB/W Murine Lupus at Early and Late Stages of Disease

    Paul Hoover1, Tom Eisenhaure 2, David Lieb 2, Anne Davidson 3 and Nir Hacohen 2, 1Brigham and Women's Hospital, Boston, MA, 2Broad Institute, Cambridge, MA, 3Feinstein Institutes for Medical Research, Manhasset

    Background/Purpose: Lupus nephritis is a complex and heterogeneous disease characterized by infiltrating immune cells in damaged kidney tissue. While mouse models have enabled mechanistic studies…
  • Abstract Number: 32 • 2018 ACR/ARHP Annual Meeting

    T Cell-Intrinsic Nod2 Protects Against Th17-Mediated Autoimmune Arthritis in SKG Mice

    Ruth Napier1, Ellen Lee1, Emily Vance1, Paige Snow2, Clare Dawson3, Kimberly Samson4, Amy Moran5, Michael Davey6, Shimon Sakaguchi7 and Holly Rosenzweig1, 1Molecular Microbiology and Immunology, Oregon Health & Science University, Portland, OR, 2Molecular Microbiology and Immunology, VA Portland Health Care System, Portland, OR, 3Portland VA, PORTLAND, OR, 4Oregon Health & Science University, Portland, OR, 5Cell, Developmental, and Cancer Biology, Oregon Health & Science University, Portland, OR, 6VA Portland Health Care System, Portland, OR, 7Osaka University, Osaka, Japan

    Background/Purpose: Nucleotide-binding oligomerization domain-containing protein 2 (Nod2) is an innate immune receptor known primarily for its role in host protection against bacterial infections. Intriguingly, Nod2…
  • Abstract Number: 48 • 2018 ACR/ARHP Annual Meeting

    In Vivo Demonstration of Tmtnf Reverse Signaling: Significance in the Therapeutic Response to Anti-TNF Agents during Murine Arthritis

    Numa Simons1, Andrey Kruglov2, Yannick Degboe3, Arnaud Constantin3, Sergei Nedospasov4, Alain Cantagrel5, Jean-Luc Davignon6 and Benjamin Rauwel6, 1Rheumatology, Purpan Hospital, Toulouse III University, Toulouse, France, 2German Rheumatism Research Centre, Berlin, Germany, 3Department of Rheumatology, Purpan Hospital, Toulouse III University, Toulouse, France, Toulouse, France, 44Engelhardt Institute of Molecular Biology, Russian Academy of Sciences, Moscow, Russian Federation, 5Center of Rheumatology of CHU, Toulouse, France, 6CPTP, INSERM UMR 1043, Toulouse, France

    In vivo demonstration of tmTNF reverse signaling: significance in the therapeutic response to anti-TNF agents during murine arthritis. N. Simons1,2, A. Kruglov 3, Y. Degboé 1,2, A.…
  • Abstract Number: 56 • 2018 ACR/ARHP Annual Meeting

    Comparison of Metabolic Changes in Osteoarthritis and Rheumatoid Arthritis Mouse Models

    Marie-Lisa Hülser1, Hani Manfred Sauermilch1, Carina Schreiyäck1, Yubin Luo2, Aline Bozec2, Georg Schett3, Ulf Müller-Ladner4 and Elena Neumann1, 1Dept. of Rheumatology and Clinical Immunology, Campus Kerckhoff, Justus-Liebig-University Gießen, Germany, Bad Nauheim, Germany, 2University of Erlangen-Nürnberg, Department Clinic of Medicine 3 - Immunology and Rheumatology, Erlangen, Germany, Erlangen, Germany, 3Friedrich-Alexander-Universität Erlangen, Nürnberg und Universitätsklinikum Erlangen, Erlangen, Germany, 4Dept. of Rheumatology and Clinical Immunology, Campus Kerckhoff, Justus-Liebig-University Giessen, Germany, Bad Nauheim, Germany

    Background/Purpose: Adipocytokines are bioactive factors produced mainly by adipose tissue. They not only regulate energy homeostasis, but also influence immune responses. Osteoarthritis (OA) is one…
  • Abstract Number: 849 • 2018 ACR/ARHP Annual Meeting

    Constructing a Macrophage Infiltration Timeline in a Murine Model of Osteoarthritis

    Cheng Zhou1,2, Vu Nguyen1,3, Nisha Sambamurthy1,2, Michael Dodge1,4 and Carla Scanzello1,2, 1Translational Musculoskeletal Research Center, CMC Veterans Affairs Medical Center, Philadelphia, PA, 2Division of Rheumatology, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, 3University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, 4Department of Orthopaedic Surgery, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA

    Background/Purpose: Macrophage infiltration in synovium (SM) and intraarticular fat pads (FP) is common in Osteoarthritis (OA), and can contribute to catabolic cytokine and protease production…
  • 1
  • 2
  • 3
  • 4
  • Next Page »
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology